CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-11 | Dhaliwal Harpreet S. Chief Technical Ops Officer | Option exercise 10b5-1 | +17,000 | $24.79 | $421K | 85,085 |
| 2026-11-11 | Dhaliwal Harpreet S. Chief Technical Ops Officer | Sale 10b5-1 | −7,135 | $67.33 | $480K | 77,950 |
| 2026-11-11 | Dhaliwal Harpreet S. Chief Technical Ops Officer | Sale 10b5-1 | −9,345 | $68.16 | $637K | 68,605 |
| 2026-11-11 | Dhaliwal Harpreet S. Chief Technical Ops Officer | Sale 10b5-1 | −520 | $68.82 | $36K | 68,085 |
| 2026-11-11 | Dhaliwal Harpreet S. Chief Technical Ops Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −17,000 | 11,000 | ||
| 2026-11-02 | Cowan Elvia SVP, Finance & CAO | Option exercise 10b5-1 | +3,000 | $25.92 | $78K | 30,860 |
| 2026-11-02 | Cowan Elvia SVP, Finance & CAO | Sale 10b5-1 | −2,414 | $60.77 | $147K | 28,446 |
| 2026-11-02 | Cowan Elvia SVP, Finance & CAO | Sale 10b5-1 | −586 | $61.55 | $36K | 27,860 |
| 2026-11-02 | Cowan Elvia SVP, Finance & CAO | Option exercise · Stock Option (right to buy) 10b5-1 | −3,000 | 71,068 | ||
| 2026-11-02 | Wassil Jim EVP, Chief Scientific Ofc, COO | Option exercise 10b5-1 | +2,250 | $5.35 | $12K | 147,685 |
| 2026-11-02 | Wassil Jim EVP, Chief Scientific Ofc, COO | Sale 10b5-1 | −1,907 | $60.78 | $116K | 145,778 |
| 2026-11-02 | Wassil Jim EVP, Chief Scientific Ofc, COO | Sale 10b5-1 | −343 | $61.57 | $21K | 145,435 |
| 2026-11-02 | Wassil Jim EVP, Chief Scientific Ofc, COO | Option exercise · Stock Option (right to buy) 10b5-1 | −2,250 | 44,148 | ||
| 2026-10-05 | Cowan Elvia SVP, Finance & CAO | Option exercise 10b5-1 | +19,000 | $25.92 | $492K | 46,860 |
| 2026-10-05 | Cowan Elvia SVP, Finance & CAO | Sale 10b5-1 | −19,000 | $86.74 | $1.6M | 27,860 |
| 2026-10-05 | Cowan Elvia SVP, Finance & CAO | Option exercise · Stock Option (right to buy) 10b5-1 | −19,000 | 74,068 | ||
| 2026-10-05 | Wassil Jim EVP, Chief Scientific Ofc, COO | Option exercise 10b5-1 | +18,000 | $5.35 | $96K | 163,435 |
| 2026-10-05 | Wassil Jim EVP, Chief Scientific Ofc, COO | Sale 10b5-1 | −18,000 | $86.74 | $1.6M | 145,435 |
| 2026-10-05 | Wassil Jim EVP, Chief Scientific Ofc, COO | Option exercise · Stock Option (right to buy) 10b5-1 | −18,000 | 46,398 | ||
| 2026-10-01 | Wassil Jim EVP, Chief Scientific Ofc, COO | Option exercise 10b5-1 | +2,250 | $5.35 | $12K | 147,685 |
Page 1 of 17 · 324 trades